We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Although 6MWT remains the standard functional measure in ATTR-CM trials, SPPB is established in the HF population and offers practical advantages: no special space, less time, ease of administration, and multidomain assessment (gait speed, balance, and chair stands) that identifies specific functional limitations.”
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Ansari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: